Skip to main content
. Author manuscript; available in PMC: 2013 Jul 10.
Published in final edited form as: Oncogene. 2008 Apr 7;27(32):4503–4508. doi: 10.1038/onc.2008.94

Figure 2.

Figure 2

Rassf1a-deficient Apc+/Min mice show decreased survival. (a) Kaplan-Meier plots show the percentages of survival of Rassf1a+/+, Rassf1a+/− and Rassf1a−/− mice on an Apc+/Min background. (b) When the mice became moribund, their intestines were collected and prepared as Swiss-rolls for histological analysis following haematoxylin-eosin staining. The processed intestines from Rassf1a+/+; Apc+/Min (n=33) and Rassf1a−/−; Apc+/Min (n=52) were analysed for the presence of adenomas (grouped into grades 1-3 based on their number and degree of dysplasia) and adenocarcinomas. (c) The age at death for mice bearing intestinal adenocarcinomas was compared between Rassf1a+/+; Apc+/Min (n=6) and Rassf1a−/−; Apc+/Min (n=9) mice. The bar indicates mean value for each genotype.

HHS Vulnerability Disclosure